Noninvasive monitoring of a murine model of metastatic pheochromocytoma: A comparison of contrast-enhanced microCT and nonenhanced MRI

Journal of Magnetic Resonance Imaging

Volumn 29, Issue 3, 2009, Pages 685-691

  Martiniova, Lucia ^a,i   Kotys, Melanie S ^b   Thomasson, David ^c   Schimel, Daniel ^d   Lai, Edwin W ^a   Bernardo, Marcelino ^e,f   Merino, Maria J ^e   Powers, James F ^g   Ruzicka, Jan ^h   Kvetnansky, Richard ⁱ   Choyke, Peter L ^e   Pacak, Karel ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

^f SAIC FREDERICK INC   (United States)

^g TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h Physics and Informatics   (Slovakia)

ⁱ INSTITUTE OF EXPERIMENTAL ENDOCRINOLOGY   (Slovakia)

Author keywords

Anatomical imaging; Animal model; Mi croCT; MRI; Pheochromocytoma

Indexed keywords

CATECHOLAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPSY; CANCER CELL CULTURE; CATECHOLAMINE BLOOD LEVEL; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; IMAGE DISPLAY; METASTASIS; MICRO-COMPUTED TOMOGRAPHY; MONITORING; MOUSE; NON INVASIVE PROCEDURE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; SIGNAL NOISE RATIO; TUMOR LOCALIZATION; TUMOR VOLUME;

ADRENAL GLAND NEOPLASMS; ANIMALS; BONE NEOPLASMS; CONTRAST MEDIA; DISEASE MODELS, ANIMAL; FEMALE; IMAGE ENHANCEMENT; IMAGE PROCESSING, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; KIDNEY NEOPLASMS; LIVER NEOPLASMS, EXPERIMENTAL; LUNG NEOPLASMS; MAGNETIC RESONANCE IMAGING; MICE; MICE, NUDE; MONITORING, PHYSIOLOGIC; PHEOCHROMOCYTOMA; SENSITIVITY AND SPECIFICITY; X-RAY MICROTOMOGRAPHY;

EID: 63449128201     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.21654     Document Type: Article

References (24)

1. Lloyd RV, Tischler AS, Kimura N. Pathology and genetics of tumours of endocrine organs. In: World Health Organization classification of tumors. Lyon: IARC; 2004:136-146.
2. Pacak K, Eisenhofer G, Goldstein DS. Functional imaging of endocrine tumors: role of positron emission tomography. Endocr Rev 2004;25:568-580.
3. Martiniova L, Ohta S, Guion P, et al. Anatomical and functional imaging of tumors in animal models: focus on pheochromocytoma. Ann N Y Acad Sci 2006;1073:392-404.
4. Ohta S, Lai EW, Morris JC, et al. Metastasis-associated gene expression profile of liver and subcutaneous lesions derived from mouse pheochromocytoma cells. Mol Carcinog 2008;47:245-251.
5. Powers JF, Evinger MJ, Tsokas P, et al. Pheochromocytoma cell lines from heterozygous neurofibromatosis knockout mice. Cell Tissue Res 2000;302:309-320.
6. Weber SM, Peterson KA, Durkee B, et al. Imaging of murine liver tumor using microCT with a hepatocyte-selective contrast agent: accuracy is dependent on adequate contrast enhancement. J Surg Res 2004;119:41-45.
7. Ohta S, Lai EW, Taniguchi S, Tischler AS, Alesci S, Pacak K. Animal models of pheochromocytoma including NIH initial experience. Ann N YAcad Sci 2006;1073:300-305.
8. Alesci S, Perera SM, Lai EW, et al. Adenoviral gene transfer in bovine adrenomedullaryand murine pheochromocytoma cells: potential clinical and therapeutic relevance. Endocrinology 2007;148:3900-3907.
9. Ohta S, Lai EW, Morris JC, et al. MicroCT for high-resolution imaging of ectopic pheochromocytoma tumors in the liver of nude mice. Int J Cancer 2006;119:2236-2241.
10. Bakan DA, Lee FT Jr, Weichert JP, Longino MA, Counsell RE. Hepatobiliary imaging using a novel hepatocyte-selective CT contrast agent. Acad Radiol 2002;9(Suppl 1):S194-199.
11. Weichert JP, Lee FT Jr, Chosy SG, et al. Combined hepatocyte-selec-tive and blood-pool contrastagents forthe CTdetectionofexperimen-tal liver tumors in rabbits. Radiology2000;216:865-871.
12. Lee FT Jr, Chosy SG, Naidu SG, et al. CT depiction of experimental liver tumors: contrast enhancement with hepatocyte-selective io-dinated triglyceride versus conventional techniques. Radiology 1997;203:465-470.
13. Weichert JP, Longino MA, Bakan DA, et al. Polyiodinated triglycer-ide analogs as potential computed tomography imaging agents for the liver. J Med Chem 1995;38:636-646.
14. Bakan DA, Longino MA, Weichert JP, Counsell RE. Physicochem-ical characterization of a synthetic lipid emulsion for hepatocyte-selective delivery of lipophilic compounds: application to polyiodi-nated triglycerides as contrast agents for computed tomography. J Pharm Sci 1996;85:908-914.
15. Abramoff MD, Magelhaes PJ, Ram SJ. Image processing with Im-ageJ. Biophoton Int 2004;11:36-42.
16. McAuliffe MJ, Lalonde FM, McGarry D, Gandler W, Csaky K, Trus BL. Medical image processing, analysis and visualization in clinical research. IEEE Comput Based Med Syst 2007:381-386.
17. Eisenhofer G, Walther MM, Huynh TT, et al. Pheochromocytomas in von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 display distinct biochemical and clinical phenotypes. J Clin Endocrinol Metab 2001;86:1999-2008.
18. Eisenhofer G, Tian H, Holmes C, Matsunaga J, Roffler-Tarlov S, Hearing VJ. Tyrosinase: a developmentally specific major determinant ofperipheral dopamine. FASEB J 2003;17:1248-1255.
19. Eisenhofer G, Aneman A, Hooper D, Holmes C, Goldstein DS, Frib-erg P. Production and metabolism of dopamine and norepinephrine in mesenteric organs and liver of swine. Am J Physiol 1995;268(4 Pt1):G641-649.
20. Goldstein RE, O'Neill JA Jr, Holcomb GW 3rd, et al. Clinical experience over 48 years with pheochromocytoma. Ann Surg 1999;229:755-764.
21. John H, Ziegler WH, Hauri D, Jaeger P. Pheochromocytomas: can malignant potential be predicted? Urology 1999;53:679-683.
22. Linnoila RI, Keiser HR, Steinberg SM, Lack EE. Histopathology of benign versus malignant sympathoadrenal paragangliomas: clini-copathologic study of 120 cases including unusual histologic features. Hum Pathol 1990;21:1168-1180.
23. Suckow CE, Stout DB. MicroCT liver contrast agent enhancement over time, dose, and mouse strain. Mol Imaging Biol 2008;10:114-120.
24. Payne JT. CT radiation dose and image quality. Radiol Clin North Am 2005;43:953-962.